These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 10557020

  • 1. The effect of sibutramine on resting energy expenditure and adrenaline-induced thermogenesis in obese females.
    Walsh KM, Leen E, Lean ME.
    Int J Obes Relat Metab Disord; 1999 Oct; 23(10):1009-15. PubMed ID: 10557020
    [Abstract] [Full Text] [Related]

  • 2. Influence of sibutramine on energy expenditure in African American women.
    Starling RD, Liu X, Sullivan DH.
    Obes Res; 2001 Apr; 9(4):251-6. PubMed ID: 11331428
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Effects of sibutramine on resting metabolic rate and weight loss in overweight women.
    Seagle HM, Bessesen DH, Hill JO.
    Obes Res; 1998 Mar; 6(2):115-21. PubMed ID: 9545017
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Pharmacological therapy of obesity].
    Pagotto U, Vanuzzo D, Vicennati V, Pasquali R.
    G Ital Cardiol (Rome); 2008 Apr; 9(4 Suppl 1):83S-93S. PubMed ID: 18773755
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study.
    Hanotin C, Thomas F, Jones SP, Leutenegger E, Drouin P.
    Int J Obes Relat Metab Disord; 1998 Jan; 22(1):32-8. PubMed ID: 9481597
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effects of sibutramine-induced weight loss on cardiovascular system in obese subjects.
    de Simone G, Romano C, De Caprio C, Contaldo F, Salanitri T, di Luzio Paparatti U, Pasanisi F.
    Nutr Metab Cardiovasc Dis; 2005 Feb; 15(1):24-30. PubMed ID: 15871847
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by beta-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial.
    Sramek JJ, Leibowitz MT, Weinstein SP, Rowe ED, Mendel CM, Levy B, McMahon FG, Mullican WS, Toth PD, Cutler NR.
    J Hum Hypertens; 2002 Jan; 16(1):13-9. PubMed ID: 11840225
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Randomized placebo-controlled trial of long-term treatment with sibutramine in mild to moderate obesity.
    Smith IG, Goulder MA, Sibutramine Clinical Study 1047 Team.
    J Fam Pract; 2001 Jun; 50(6):505-12. PubMed ID: 11407998
    [Abstract] [Full Text] [Related]

  • 18. Effects of sibutramine on thermogenesis in obese patients assessed via immersion calorimetry.
    Saraç F, Pehlivan M, Celebi G, Saygili F, Yilmaz C, Kabalak T.
    Adv Ther; 2006 Jun; 23(6):1016-29. PubMed ID: 17276969
    [Abstract] [Full Text] [Related]

  • 19. Sibutramine. A review of its contribution to the management of obesity.
    McNeely W, Goa KL.
    Drugs; 1998 Dec; 56(6):1093-124. PubMed ID: 9878996
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.